Stable Isotope Analyzer MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy Isotope ElementBy End UserBy Offering
Full title & scope — all 5 axes with their segments
Stable Isotope Analyzer Market Size, Share & Industry Analysis, By Type (Stable Isotope Ratio Mass Spectrometer, Laser-based Stable Isotope Analysis), By Application (Environmental Sciences, Food Analysis, Medical, Industrial), By Isotope Element (Carbon, Nitrogen, Oxygen, Hydrogen, Sulfur & Others), By End User (Academic & Research Institutes, Environmental & Regulatory Agencies, Food & Beverage Industry, Pharmaceutical & Biotechnology Companies, Others), By Offering (Instruments, Software & Services), and Regional Forecast, 2026-2034
How the estimates were built: data sources, modelling approach and validation steps.
- 01By TypeStable Isotope Ratio Mass Spectrometer · Laser-based Stable Isotope Analysis
- 02By ApplicationEnvironmental Sciences · Food Analysis · Medical
- 03By Isotope ElementCarbon · Nitrogen · Oxygen
- 04By End UserAcademic & Research Institutes · Environmental & Regulatory Agencies · Food & Beverage Industry
- 05By OfferingInstruments · Software & Services
- 06By Region
Market Analysis & Outlook
A stable isotope analyzer measures the relative abundance of naturally occurring isotopes, such as carbon, nitrogen, oxygen, hydrogen and sulfur, in a sample using either isotope-ratio mass spectrometry or laser-based absorption spectroscopy. The instruments are used to authenticate food and beverage origin, trace pollutant sources in water, soil and air, support ecological and hydrological research, and run metabolic or pharmacokinetic tracer studies in clinical and pharmaceutical settings. Buyers range from university and government research laboratories to food-testing and environmental-monitoring labs, contract research organizations, and pharmaceutical and biotechnology companies.
Between 2025 and 2034 the global stable isotope analyzer market moves from USD 640 million to USD 1835 million, compounding at 12.5% a year. Fifteen years are covered in all, taking in USD 280 million in 2020, USD 545 million in 2024, USD 715 million in 2026 and USD 1145 million in 2030.
69.79% of 2025 revenue sits in Stable Isotope Ratio Mass Spectrometer, worth USD 446.66 million and rising to USD 1009.25 million at 55% by 2034, the largest type line in both years. Growth is fastest in Laser-based Stable Isotope Analysis at 17.47% and slowest in Stable Isotope Ratio Mass Spectrometer at 9.53%. The lines gaining share are Laser-based Stable Isotope Analysis. Stable Isotope Ratio Mass Spectrometer lose share without losing revenue.
Cut by application, the largest line is Environmental Sciences: 34% of 2025 revenue, worth USD 217.6 million, and 32% at USD 587.2 million by 2034. Medical grows faster at 14.03% against 11.66%, moving from 22% of revenue to 25% by 2034. Both this axis and the type one divide the same revenue, which is why they are alternative views, not components.
North America is the largest region at 32% of 2025 revenue, worth USD 204.8 million and reaching USD 495.45 million by 2034. Europe follows at 28%, moving from USD 179.2 million to USD 440.4 million, and Middle East and Africa is the smallest at 6%. Asia Pacific gain share across the period, so growth is not distributed evenly between regions.
The 2025 total is a triangulation of published figures and category proxies, short of a directly sourced total. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, two type lines and five segmentation axes across a fifteen-year window.
Market Size, 2020–2034
USD MillionRevenue in USD Million. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- A forecast-period rate of 12.5% takes the market from USD 640 million in 2025 to USD 1835 million in 2034, against 17.98% recorded over the 2020-2025 historical period.
- Stable Isotope Ratio Mass Spectrometer is the largest type line at USD 446.66 million in 2025, a 69.79% share, reaching USD 1009.25 million and 55% of revenue by 2034.
- At 17.47%, Laser-based Stable Isotope Analysis grows faster than any other type line, moving from USD 193.34 million and 30.21% of revenue in 2025 to USD 825.75 million and 45% in 2034.
- Scenario range for 2034 runs from USD 1578 million in the bear case to USD 2092 million in the bull case, against a base-case USD 1835 million, the spread a plan built on this forecast has to absorb.
- North America holds 32% of global revenue in 2025 at USD 204.8 million, the largest of the five regions tracked, and reaches USD 495.45 million by 2034.
- 85% of North America's base-year revenue comes from the United States alone: USD 174.08 million in 2025, rising to USD 421.13 million by 2034, which is why it is that region's worked example.
- Fifteen years are reported, 2020 to 2034 with 2025 as the base: revenue, share and growth rate per line, per axis and per region, not as a single blended series.
Market Trends
Revenue Share, By by type
Base year 2025Stable Isotope Ratio Mass Spectrometer leads with 69.8% of by type segment revenue.
Share of by type segment revenue, most recent base year.
Read across the forecast period, the global stable isotope analyzer market shows movement in three places: type composition, regional weight, and the 12.5% rate applied to the whole.
None of them reverses the market's direction. Every line and every region grows in absolute terms across the period; the movement is in which of them captures the revenue added.
Laser-based Stable Isotope Analysis outpaces Stable Isotope Ratio Mass Spectrometer. The widest spread on the type axis is between Laser-based Stable Isotope Analysis at 17.47% and Stable Isotope Ratio Mass Spectrometer at 9.53%. Over the forecast period that moves Laser-based Stable Isotope Analysis from 30.21% of revenue to 45%, and Stable Isotope Ratio Mass Spectrometer from 69.79% to 55%. The revenue figures behind that are USD 193.34 million to USD 825.75 million and USD 446.66 million to USD 1009.25 million. Both expand; where a supplier sits on the axis still decides whether it tracks the market.
The regional balance moves. Asia Pacific moves from 27% of revenue in 2025 to 36% in 2034, worth USD 172.8 million rising to USD 660.6 million. The remaining regions grow in absolute terms while giving up share: North America at 32% moving to 27%, Europe at 28% moving to 24%, Latin America at 7% moving to 7%, Middle East and Africa at 6% moving to 6%. Growth is therefore not something a participant inherits from the market; it depends on which regions its revenue is weighted toward.
Growth compounds at 12.5% without a step change. Fifteen years of revenue run USD 280 million in 2020, USD 545 million in 2024, USD 640 million in 2025, USD 715 million in 2026, USD 1145 million in 2030 and USD 1835 million in 2034. The forecast rate of 12.5% sits against 17.98% over the historical period, so the projection extends an observed trend instead of proposing a new one. The risk in the number sits in the mix assumptions, not in whether the market grows at all, which is where the type and regional sections come in.
Market Growth Factors
Laser-based Stable Isotope Analysis adds the most incremental growth
Market Drivers
3- 01Laser-based Stable Isotope Analysis adds the most incremental growth
The fastest line on the type axis is Laser-based Stable Isotope Analysis, at 17.47% against the market's 12.5%, taking USD 193.34 million to USD 825.75 million and 30.21% of revenue to 45%. The market's overall 12.5% depends on that rate holding: at the 9.53% recorded by Stable Isotope Ratio Mass Spectrometer, the same revenue base would compound to a materially smaller 2034 total. Where a supplier sits on this axis therefore decides whether it grows with the market or below it.
- 02Regional weight, not regional count
North America is the largest region at USD 204.8 million in 2025, 32% of global revenue, and reaches USD 495.45 million by 2034 while holding 27%. Europe adds a further 28% at USD 179.2 million, reaching USD 440.4 million. Between them they hold most of the base and most of the revenue added over the period, so equal-weighting the regions in a plan misstates where the growth is.
- 03Fifteen years of unbroken growth underpin the forecast
The historical period compounded at 17.98%; USD 280 million in 2020, USD 545 million in 2024 and USD 640 million in 2025. The forecast period then runs at 12.5%, ending 2034 at USD 1835 million. A forecast extending an observed trend is a different proposition from one proposing a turn, and that is why no ramp is applied: the 12.5% runs evenly across the period.
Growth drivers
| # | Growth driver | Impact | Gross contribution (Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Expansion of food authenticity and origin-traceability testing mandates | High | +380 | High | High | Medium |
| 2 | Growth in environmental monitoring and carbon-cycle research programs | High | +320 | High | High | High |
| 3 | Falling entry cost as laser-based analyzers displace mass spectrometry in routine work | Medium-High | +260 | Medium | High | High |
| 4 | Rising use of stable isotope tracers in clinical and metabolic diagnostics | Medium-High | +210 | Medium | High | High |
| 5 | Expansion of isotope-tracer studies in pharmaceutical and biotech drug development | Medium | +150 | Low | Medium | High |
| 6 | Others | Low | +70 | Low | Low | Low |
| Total | +1390 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (Million) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | High instrument capital cost limiting adoption among smaller laboratories | Medium-High | −90 | High | Medium | Medium |
| 2 | Shortage of personnel skilled in interpreting isotope-ratio data | Medium | −60 | Medium | Medium | Medium |
| 3 | Multi-year public-agency budget cycles slowing environmental-testing procurement | Medium | −45 | Medium | Low | Low |
| Total | −195 | |||||
Drivers contribute 1390 Million and restraints remove 195 Million, a net 1195 Million, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
The 12.5% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the type axis, and where regional growth is concentrated.
Restraining Factors
Downside case: USD 1578 million by 2034, against USD 1835 million in the base case
Market Restraints
2- 01Downside case: USD 1578 million by 2034, against USD 1835 million in the base case
A bear case of USD 1578 million in 2034, against USD 1835 million in the base case, rests on one stated assumption: public-sector environmental agency budgets tighten further and the shortage of personnel skilled in isotope-ratio interpretation persists longer than expected, delaying instrument replacement cycles and pushing planned laboratory expansions beyond the forecast window. Neither case changes the USD 640 million 2025 base.
- 02Stable Isotope Ratio Mass Spectrometer holds the blended rate down
Stable Isotope Ratio Mass Spectrometer carries 69.79% of 2025 revenue at USD 446.66 million but compounds at 9.53% against 12.5% for the market, taking its share to 55% by 2034 even as revenue rises to USD 1009.25 million. Because it carries that much of the base, its pace holds the blended rate down more than any faster line lifts it.
Market Opportunities
Upside case: USD 2092 million by 2034
Market Opportunities
2- 01Upside case: USD 2092 million by 2034
What would beat the forecast: faster-than-expected rollout of food-fraud and provenance-testing mandates across major export markets, combined with quicker replacement-cycle adoption of lower-cost laser-based analyzers, pulls forward laboratory purchases that would otherwise land later in the forecast. That case reaches USD 2092 million in 2034 against USD 1835 million, and it is worth testing against a reader's own read of the market.
- 02Laser-based Stable Isotope Analysis share moves from 30.21% to 45%
Laser-based Stable Isotope Analysis grows at 17.47% against 12.5% for the market, adding revenue from USD 193.34 million in 2025 to USD 825.75 million in 2034 and taking its share from 30.21% to 45%. It is the place on this axis where share changes hands at scale, so it is where an entrant can take position without displacing the incumbent in Stable Isotope Ratio Mass Spectrometer.
Market Challenges
The total depends on a single line
Market Challenges
2- 01The total depends on a single line
USD 446.66 million of 2025 revenue sits in Stable Isotope Ratio Mass Spectrometer, 69.79% of the total, and it is still 55% at USD 1009.25 million nine years later. A market leaning this heavily on one type line concentrates its exposure there, and a shift in demand for that line moves the total more than any other single change on the axis.
- 02Single-country exposure in North America
Of North America's USD 204.8 million in 2025, USD 174.08 million (85%) comes from the United States alone, rising to USD 421.13 million by 2034. Read as a region it looks diversified; read by weight it is not, and the regional forecast inherits whatever happens in that one market.
Segmentation Analysis
5 axesThe market is divided by type and by application, isotope element, end user and offering; five axes in all. Every one of them divides the same revenue, which makes them views of one market from different commercial angles, not components of it.
Two type lines are reported. One of them takes share over the forecast period and the other gives it up, though every line grows in absolute terms between 2025 and 2034.
By Type · 2 segments
Scale in Stable Isotope Ratio Mass Spectrometer and Growth in Laser-based Stable Isotope Analysis Define the Type Axis
- Largest Stable Isotope Ratio Mass Spectrometer · 69.8%
- Fastest Laser-based Stable Isotope Analysis · 17.5%
- Moves most Stable Isotope Ratio Mass Spectrometer · -14.8 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Stable Isotope Ratio Mass Spectrometer | $447M | 69.8% | $1009M | 55%-14.8 | 9.5% |
| Laser-based Stable Isotope Analysis | $193M | 30.2% | $826M | 45%+14.8 | 17.5% |
Isotope-ratio mass spectrometers lead this axis because they remain the reference method for regulatory and high-stakes research work, backed by decades of established calibration protocols and a large installed base inside university and government laboratories. Laser-based analyzers grow fastest because their lower capital cost, field portability and faster sample throughput are steadily closing the precision gap with mass spectrometry, drawing in laboratories that previously could not justify the larger instrument. Stable Isotope Ratio Mass Spectrometer remains the largest line through 2034, so the axis changes in proportion, not in order. This is the axis the estimation prices in full, year by year, and the one the regional chapters cut against.
By Application · 4 segments
Environmental Sciences Held the Dominant Share of the Application Segment in 2025
- Largest Environmental Sciences · 34%
- Fastest Medical · 14%
- Moves most Medical · +3 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Environmental Sciences | $218M | 34% | $587M | 32%-2 | 11.7% |
| Food Analysis | $179M | 28% | $551M | 30%+2 | 13.3% |
| Medical | $141M | 22% | $459M | 25%+3 | 14% |
| Industrial | $102M | 16% | $239M | 13%-3 | 9.8% |
Environmental sciences leads this axis because water, soil and air isotope-fingerprinting programs are mandated by long-established public agencies with reliable, recurring procurement budgets. Medical applications grow fastest because breath-test and metabolic-tracer diagnostics are expanding into routine clinical use, a pace that outstrips environmental programs constrained by multi-year public funding cycles. The order does not change: Environmental Sciences is still largest in 2034, and what moves is how much it holds.
By Isotope Element · 5 segments
Scale in Carbon and Growth in Hydrogen Define the Isotope element Axis
- Largest Carbon · 38%
- Fastest Hydrogen · 15.2%
- Moves most Carbon · -3 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Carbon | $243M | 38% | $642M | 35%-3 | 11.4% |
| Nitrogen | $154M | 24% | $422M | 23%-1 | 11.9% |
| Oxygen | $128M | 20% | $385M | 21%+1 | 13% |
| Hydrogen | $76.80M | 12% | $275M | 15%+3 | 15.2% |
| Sulfur & Others | $38.40M | 6% | $110M | 6% | 12.4% |
Carbon leads this axis because carbon-isotope methods have the longest track record in food-authentication and ecological-tracer work, with the deepest reference libraries and the most laboratories already equipped to run them. Hydrogen grows fastest because deuterium and hydrogen-isotope methods have only recently reached production-grade reliability, opening new use in provenance testing and doping control that carbon-based methods cannot address. Carbon remains the largest line through 2034, so the axis changes in proportion, not in order.
By End User · 5 segments
Academic & Research Institutes Led by End user in 2025, with Pharmaceutical & Biotechnology Companies Growing Fastest
- Largest Academic & Research Institutes · 36%
- Fastest Pharmaceutical & Biotechnology Companies · 17.6%
- Moves most Academic & Research Institutes · -6 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Academic & Research Institutes | $230M | 36% | $551M | 30%-6 | 10.2% |
| Environmental & Regulatory Agencies | $166M | 26% | $440M | 24%-2 | 11.4% |
| Food & Beverage Industry | $128M | 20% | $404M | 22%+2 | 13.6% |
| Pharmaceutical & Biotechnology Companies | $76.80M | 12% | $330M | 18%+6 | 17.6% |
| Others | $38.40M | 6% | $110M | 6% | 12.4% |
Academic and research institutes lead this axis because decades of installed base inside university and government laboratories make isotope-ratio analysis a core, ongoing analytical service, not a one-time purchase. Pharmaceutical and biotechnology companies grow fastest because tracer-based metabolic and pharmacokinetic studies are moving from specialist contract laboratories into in-house discovery workflows, a shift that is still early and therefore has the most room left to run. By 2034 Academic & Research Institutes is still ahead, making this a shift in weight, not a change of leader.
By Offering · 2 segments
Software & Services Outpaces the Axis While Instruments Holds the Largest Share
- Largest Instruments · 82%
- Fastest Software & Services · 16.1%
- Moves most Instruments · -6 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Instruments | $525M | 82% | $1395M | 76%-6 | 11.5% |
| Software & Services | $115M | 18% | $440M | 24%+6 | 16.1% |
Instruments remain the larger line because every deployment requires capital hardware, and the installed base keeps expanding as new laboratories enter the market. Software and services grow fastest because laboratories increasingly add subscription-based data-management and calibration-support tools on top of instruments they already own, a lower-friction purchase than replacing the hardware itself. The order does not change: Instruments is still largest in 2034, and what moves is how much it holds.
Regional Insights
Regional Revenue Share
Base year 2025Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The largest region covered — 5 points of share move elsewhere by 2034, while revenue still grows 2.4×.
- Rank 1 of 5
- 2025 share 32%
- By 2034 27%
- Revenue $205M → $495M
32% of the global stable isotope analyzer market sits in North America in 2025, worth USD 204.8 million and reaches USD 495.45 million by 2034. By revenue it sits first across the study, and the ranking does not change between 2025 and 2034.
27% of global revenue sits here in 2034, below the 2025 level, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.
Within the region the type split tracks the global one; 69.79% of 2025 revenue in Stable Isotope Ratio Mass Spectrometer, fastest growth of 17.47% in Laser-based Stable Isotope Analysis. The full report breaks North America out along every axis and by country.
United States
Sets the pace for North America at 85% of it, growing 2.4×.
- In region 1 of 2
- Of region 85%
- Of global 27.2%
- Revenue $174M → $421M
85% of North America's base-year revenue comes from the United States; USD 174.08 million, rising to USD 421.13 million by 2034. At 85% of regional revenue in the base year it is not one market among several, the region's trajectory is largely this country's trajectory. Against regional totals of USD 204.8 million in 2025 and USD 495.45 million in 2034, it is the country the full report breaks out in detail.
the United States buys along the same lines as the market globally; Stable Isotope Ratio Mass Spectrometer first at 69.79% of 2025 revenue and 55% in 2034, Laser-based Stable Isotope Analysis fastest at 17.47% on a share moving from 30.21% to 45%. Since 85% of North America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Revenue by type for the United States is reported separately in the full report.
Stable isotope analyzers sold into research, environmental, and clinical laboratory settings in the United States fall primarily under the purview of the Environmental Protection Agency and the Food and Drug Administration, depending on end use. Instruments intended for diagnostic or clinical breath-test applications, such as those measuring isotopic ratios in exhaled carbon dioxide, are treated as medical devices and must meet FDA premarket clearance requirements along with quality system regulation for manufacturing. Analyzers deployed for environmental monitoring or emissions verification are expected to conform to EPA reference or equivalent methods for measurement accuracy. Electrical safety and electromagnetic compatibility are governed by voluntary consensus standards bodies such as Underwriters Laboratories. Suppliers must maintain calibration traceability to national metrology standards and provide documentation supporting measurement uncertainty claims to end users in regulated industries.
Competition in the United States runs between the suppliers this study tracks: Picarro, Elementar, Los Gatos Research, Thermo Fisher Scientific, Nu Instruments and Sercon. Two different problems sit on the same axis: holding Stable Isotope Ratio Mass Spectrometer at 69.79% of 2025 revenue, and taking Laser-based Stable Isotope Analysis while it grows at 17.47%. Country-level shares and positioning per company sit in the full report.
Canada
2nd-largest in North America, growing 2.4×.
- In region 2 of 2
- Of region 15%
- Of global 4.8%
- Revenue $30.72M → $74.32M
Canada is sized at USD 30.72 million in 2025, rising to USD 74.32 million by 2034; 4.8% of global revenue and 15% of North America. It is reported separately from the United States across every segmentation axis in the full report.
Europe Market Analysis
The 2nd-largest region covered — 4 points of share move elsewhere by 2034, while revenue still grows 2.5×.
- Rank 2 of 5
- 2025 share 28%
- By 2034 24%
- Revenue $179M → $440M
In Europe, 28% of global revenue puts 2025 at USD 179.2 million with USD 440.4 million projected for 2034. That makes it the second-largest region covered, in 2025 and again in 2034.
Share settles at 24% in 2034, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.
Segment composition follows the global pattern: Stable Isotope Ratio Mass Spectrometer largest at 69.79% of 2025 revenue, Laser-based Stable Isotope Analysis fastest at 17.47%. Per-axis and per-country detail for Europe sits in the full report.
Germany
The largest market in Europe, growing 2.3×.
- In region 1 of 3
- Of region 40%
- Of global 11.2%
- Revenue $71.68M → $167M
The largest single market in Europe is Germany, at USD 71.68 million in 2025 and USD 167.35 million in 2034. 40% of the region in the base year makes it the largest market here without making it the region. The region itself runs USD 179.2 million to USD 440.4 million over the same period, and this is the market carrying the country-level detail in the full report.
Demand in Germany follows the type mix reported at global level: Stable Isotope Ratio Mass Spectrometer is the largest line at 69.79% of 2025 revenue, moving to 55% by 2034, while Laser-based Stable Isotope Analysis grows fastest at 17.47% and takes its share from 30.21% to 45%. With 40% of Europe concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by type for Germany is reported separately in the full report.
As a member state of the European Union, Germany applies the EU framework governing measuring instruments and, where relevant, medical devices to stable isotope analyzers. Instruments used in clinical or diagnostic contexts, including isotope-ratio breath testing, fall under the EU In Vitro Diagnostic Regulation and require conformity assessment before a manufacturer may affix the CE mark. Analyzers used in industrial, environmental, or research settings must comply with the EU framework on electromagnetic compatibility and low-voltage equipment safety, alongside general product safety obligations enforced nationally by German market surveillance authorities. Laboratories using these instruments for accredited testing are generally expected to operate under the ISO/IEC standard for testing and calibration laboratory competence. Suppliers must issue a declaration of conformity and ensure technical documentation is available to German and EU regulators upon request.
Competition in Germany runs between the suppliers this study tracks: Picarro, Elementar, Los Gatos Research, Thermo Fisher Scientific, Nu Instruments and Sercon. The commercially relevant division is 69.79% of 2025 revenue in Stable Isotope Ratio Mass Spectrometer, where the volume is, against 17.47% growth in Laser-based Stable Isotope Analysis, where share moves. Weighting toward Europe means competing for 28% of 2025 global revenue, a base of USD 179.2 million moving to USD 440.4 million across the forecast period.
United Kingdom
2nd-largest in Europe, growing 2.4×.
- In region 2 of 3
- Of region 28%
- Of global 7.8%
- Revenue $50.18M → $119M
7.84% of global revenue is generated in the United Kingdom; USD 50.18 million in 2025, reaching USD 118.91 million in 2034, and 28% of Europe.
France
3rd-largest in Europe, growing 2.3×.
- In region 3 of 3
- Of region 20%
- Of global 5.6%
- Revenue $35.84M → $83.68M
5.6% of global revenue is generated in France; USD 35.84 million in 2025, reaching USD 83.68 million in 2034, and 20% of Europe.
Asia Pacific Market Analysis
The 3rd-largest region covered, and the one gaining the most — it picks up 9 points of share by 2034, while revenue still grows 3.8×.
- Rank 3 of 5
- 2025 share 27%
- By 2034 36%
- Revenue $173M → $661M
Asia Pacific holds 27% of the global stable isotope analyzer market in 2025, worth USD 172.8 million with USD 660.6 million projected for 2034. Among the five regions it ranks third by revenue in both years.
By 2034 the share has moved up to 36%, so the region grows faster than the market's 12.5% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
Segment composition follows the global pattern: Stable Isotope Ratio Mass Spectrometer largest at 69.79% of 2025 revenue, Laser-based Stable Isotope Analysis fastest at 17.47%. Asia Pacific is reported axis by axis and country by country in the full study.
China
The largest market in Asia Pacific, growing 3.6×.
- In region 1 of 3
- Of region 42%
- Of global 11.3%
- Revenue $72.58M → $264M
USD 72.58 million of Asia Pacific's 2025 revenue is generated in China, the region's largest market, reaching USD 264.24 million by 2034. At 42% of the region in 2025 it leads, but a majority of Asia Pacific's revenue is generated in other markets. The region itself runs USD 172.8 million to USD 660.6 million over the same period, and this is the market carrying the country-level detail in the full report.
China buys along the same lines as the market globally; Stable Isotope Ratio Mass Spectrometer first at 69.79% of 2025 revenue and 55% in 2034, Laser-based Stable Isotope Analysis fastest at 17.47% on a share moving from 30.21% to 45%. Because the country carries 42% of Asia Pacific, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. China carries its own type breakdown in the full report.
In China, stable isotope analyzers are subject to oversight from the State Administration for Market Regulation, which governs measuring instrument compliance and, through its subordinate certification bodies, applies the China Compulsory Certification scheme where the instrument's classification requires it. Devices intended for clinical or diagnostic use, such as isotope breath-test systems, additionally fall under the jurisdiction of the National Medical Products Administration and must undergo registration before commercial distribution. Import of scientific and analytical instruments also requires customs clearance documentation confirming conformity with national metrology law, administered through China's national institute of metrology for calibration traceability. Suppliers are expected to label instruments in Chinese with accurate technical specifications and to retain manufacturing quality records consistent with national standards for electrical and safety compliance before instruments reach laboratory or industrial end users.
In China the field is Picarro, Elementar, Los Gatos Research, Thermo Fisher Scientific, Nu Instruments and Sercon. The commercially relevant division is 69.79% of 2025 revenue in Stable Isotope Ratio Mass Spectrometer, where the volume is, against 17.47% growth in Laser-based Stable Isotope Analysis, where share moves. A supplier weighted toward Asia Pacific is competing over a base of USD 172.8 million in 2025 reaching USD 660.6 million by 2034, 27% of global revenue at the start of that period.
Japan
2nd-largest in Asia Pacific, growing 3.2×.
- In region 2 of 3
- Of region 24%
- Of global 6.5%
- Revenue $41.47M → $132M
Japan is sized at USD 41.47 million in 2025, rising to USD 132.12 million by 2034; 6.48% of global revenue and 24% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
India
3rd-largest in Asia Pacific, growing 4.9×.
- In region 3 of 3
- Of region 14%
- Of global 3.8%
- Revenue $24.19M → $119M
3.78% of global revenue is generated in India; USD 24.19 million in 2025, reaching USD 118.91 million in 2034, and 14% of Asia Pacific.
Latin America Market Analysis
The 4th-largest region covered, holding its share flat through 2034, while revenue still grows 2.9×.
- Rank 4 of 5
- 2025 share 7%
- By 2034 7%
- Revenue $44.80M → $128M
7% of the global stable isotope analyzer market sits in Latin America in 2025, worth USD 44.8 million on the way to USD 128.45 million by 2034. It is a marginal region on this axis, fourth by revenue throughout the period.
By 2034 the share stands at 7%, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
Segment composition follows the global pattern: Stable Isotope Ratio Mass Spectrometer largest at 69.79% of 2025 revenue, Laser-based Stable Isotope Analysis fastest at 17.47%. Latin America is reported axis by axis and country by country in the full study.
Brazil
The largest market in Latin America, growing 2.9×.
- In region 1 of 2
- Of region 55%
- Of global 3.9%
- Revenue $24.64M → $70.65M
55% of Latin America's base-year revenue comes from Brazil; USD 24.64 million, rising to USD 70.65 million by 2034. Its 55% of base-year regional revenue leads the region, though enough sits elsewhere that Latin America is not a proxy for it. Against regional totals of USD 44.8 million in 2025 and USD 128.45 million in 2034, it is the country the full report breaks out in detail.
Demand in Brazil follows the type mix reported at global level: Stable Isotope Ratio Mass Spectrometer is the largest line at 69.79% of 2025 revenue, moving to 55% by 2034, while Laser-based Stable Isotope Analysis grows fastest at 17.47% and takes its share from 30.21% to 45%. Since 55% of Latin America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-type revenue for Brazil appears on its own in the full report.
In Brazil, stable isotope analyzers used for clinical, diagnostic, or in vitro diagnostic applications are regulated by the National Health Surveillance Agency, known as Anvisa, which requires product registration and evidence of safety and performance before commercial sale. Instruments intended for environmental, agricultural, or industrial research use instead fall under general metrology oversight administered by the National Institute of Metrology, Quality and Technology, which sets calibration and measurement accuracy requirements for scientific instrumentation. Electrical safety conformity is assessed against standards maintained by the Brazilian Association of Technical Standards, and compliant products typically carry the national conformity mark. Suppliers must provide Portuguese-language labelling and technical documentation, and importers are responsible for ensuring customs and regulatory filings are completed prior to instrument deployment in Brazilian laboratories or facilities.
The suppliers tracked in this study (Picarro, Elementar, Los Gatos Research, Thermo Fisher Scientific, Nu Instruments and Sercon) compete in Brazil across the type lines above. The commercially relevant division is 69.79% of 2025 revenue in Stable Isotope Ratio Mass Spectrometer, where the volume is, against 17.47% growth in Laser-based Stable Isotope Analysis, where share moves. Weighting toward Latin America means competing for 7% of 2025 global revenue, a base of USD 44.8 million moving to USD 128.45 million across the forecast period.
Mexico
2nd-largest in Latin America, growing 2.9×.
- In region 2 of 2
- Of region 30%
- Of global 2.1%
- Revenue $13.44M → $38.54M
Mexico is sized at USD 13.44 million in 2025, rising to USD 38.54 million by 2034; 2.1% of global revenue and 30% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.
Middle East and Africa Market Analysis
The 5th-largest region covered, holding its share flat through 2034, while revenue still grows 2.9×.
- Rank 5 of 5
- 2025 share 6%
- By 2034 6%
- Revenue $38.40M → $110M
6% of the global stable isotope analyzer market sits in Middle East and Africa in 2025, worth USD 38.4 million and reaches USD 110.1 million by 2034. Among the five regions it ranks fifth by revenue in both years.
By 2034 the share stands at 6%, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.
Segment composition follows the global pattern: Stable Isotope Ratio Mass Spectrometer largest at 69.79% of 2025 revenue, Laser-based Stable Isotope Analysis fastest at 17.47%. Per-axis and per-country detail for Middle East and Africa sits in the full report.
Saudi Arabia
The largest market in Middle East and Africa, growing 2.7×.
- In region 1 of 2
- Of region 40%
- Of global 2.4%
- Revenue $15.36M → $41.84M
40% of Middle East and Africa's base-year revenue comes from Saudi Arabia; USD 15.36 million, rising to USD 41.84 million by 2034. Its 40% of base-year regional revenue leads the region, though enough sits elsewhere that Middle East and Africa is not a proxy for it. The region itself runs USD 38.4 million to USD 110.1 million over the same period, and this is the market carrying the country-level detail in the full report.
Saudi Arabia buys along the same lines as the market globally; Stable Isotope Ratio Mass Spectrometer first at 69.79% of 2025 revenue and 55% in 2034, Laser-based Stable Isotope Analysis fastest at 17.47% on a share moving from 30.21% to 45%. Its 40% weight in Middle East and Africa means those movements carry straight into the regional totals. Saudi Arabia carries its own type breakdown in the full report.
In Saudi Arabia, stable isotope analyzers intended for clinical or diagnostic applications are regulated by the Saudi Food and Drug Authority, which requires medical device registration and conformity to its national marketing authorization requirements before a supplier may sell into hospital or laboratory settings. Instruments used for industrial, environmental, or research purposes instead fall under the general product conformity framework administered by the Saudi Standards, Metrology and Quality Organization, which sets requirements for calibration integrity and electrical safety consistent with internationally recognized standards. Products crossing the border are also subject to the Gulf technical regulation for low-voltage equipment where applicable across the wider Gulf Cooperation Council market. Suppliers are expected to provide Arabic-language labelling, maintain traceable calibration certificates, and register with the relevant authority before instruments are cleared for import and use.
The suppliers tracked in this study (Picarro, Elementar, Los Gatos Research, Thermo Fisher Scientific, Nu Instruments and Sercon) compete in Saudi Arabia across the type lines above. The commercially relevant division is 69.79% of 2025 revenue in Stable Isotope Ratio Mass Spectrometer, where the volume is, against 17.47% growth in Laser-based Stable Isotope Analysis, where share moves. The commercial size of that position is USD 38.4 million in 2025 and USD 110.1 million by 2034, 6% of the global total in the base year.
South Africa
2nd-largest in Middle East and Africa, growing 2.7×.
- In region 2 of 2
- Of region 30%
- Of global 1.8%
- Revenue $11.52M → $30.83M
1.8% of global revenue is generated in South Africa; USD 11.52 million in 2025, reaching USD 30.83 million in 2034, and 30% of Middle East and Africa.
Request this sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by type, application, isotope element, end user, offering, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Scale in Stable Isotope Ratio Mass Spectrometer and Growth in Laser-based Stable Isotope Analysis Set the Terms of Competition
Suppliers in scope: Picarro, Elementar, Los Gatos Research, Thermo Fisher Scientific, Nu Instruments and Sercon.
Where suppliers actually compete is along the type axis. 69.79% of 2025 revenue, worth USD 446.66 million, is in Stable Isotope Ratio Mass Spectrometer, still 55% of the total in 2034; that is the position least likely to change hands. Laser-based Stable Isotope Analysis, compounding at 17.47% against 9.53% for Stable Isotope Ratio Mass Spectrometer, is where share changes hands over the forecast period. The two rarely sit with the same supplier, and that is the reason a USD 640 million market is not already consolidated.
Suppliers compete chiefly on measurement precision and repeatability, since isotope-ratio results must be comparable across laboratories and over time. Mass-spectrometry specialists such as Thermo Fisher Scientific and Nu Instruments hold an edge in reference-grade precision and established calibration protocols, which keeps them favored for regulatory and high-stakes research work. Laser-based entrants including Picarro and Los Gatos Research compete on lower capital cost, portability and faster sample turnaround, opening adoption among labs that could not previously justify a mass spectrometer. Smaller regional suppliers such as Elementar and Sercon compete instead on service responsiveness and applications support, an advantage in food and environmental testing where regional presence speeds turnaround.
The regional picture sets the entry cost: 32% of revenue is in North America and 28% in Europe, so a credible global position requires both, while Middle East and Africa at 6% can be served opportunistically.
Profiles, financials, shares and development histories for each company sit in the full report; this summary carries the structure only.
List of Key Stable Isotope Analyzer Market Companies Profiled
6 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- Picarro(United States)
- Elementar(Germany)
- Los Gatos Research(United States)
- Thermo Fisher Scientific(United States)
- Nu Instruments(United Kingdom)
- Sercon(United Kingdom)
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 5 axes (Type, Application, Isotope Element, End User, Offering), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 6 key companies, and the research methodology behind every estimate.
Segmentation
5 axes + regionFull chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
Chapter 2.Premium Insights
Chapter 3.Market Definition
Chapter 4.Research Methodology
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
Chapter 7.Market Trends, Strategy & Dynamics
Chapter 8.Porter's Five Forces
Chapter 9.PESTEL Analysis
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
Chapter 13.Market Cost Analysis
Chapter 14.Market Supply-Side Analysis
Chapter 15.Global Stable Isotope Analyzer Market Size & Projections, 2020–2034, Revenue (USD Million)
Chapter 16.Global Stable Isotope Analyzer Market Overview, By Type, 2020–2034, Revenue (USD Million)
Chapter 17.Global Stable Isotope Analyzer Market Overview, By Application, 2020–2034, Revenue (USD Million)
Chapter 18.Global Stable Isotope Analyzer Market Overview, By Isotope Element, 2020–2034, Revenue (USD Million)
Chapter 19.Global Stable Isotope Analyzer Market Overview, By End User, 2020–2034, Revenue (USD Million)
Chapter 20.Global Stable Isotope Analyzer Market Overview, By Offering, 2020–2034, Revenue (USD Million)
Chapter 21.Global Stable Isotope Analyzer Market Size — Segment Comparison
Chapter 22.Global Stable Isotope Analyzer Geography Overview, 2020–2034, Revenue (USD Million)
Chapter 23.North America Stable Isotope Analyzer Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 24.Europe Stable Isotope Analyzer Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 25.Asia Pacific Stable Isotope Analyzer Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 26.Latin America Stable Isotope Analyzer Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 27.Middle East and Africa Stable Isotope Analyzer Market Deep-Dive, 2020–2034, Revenue (USD Million)
Chapter 28.Application / Use-Case Analysis
Chapter 29.Vendor Capability Scorecard
Chapter 30.Scenario Forecasts
Chapter 31.Top 10 Key Clients of Top 10 Players
Chapter 32.Top 10 Suppliers
Chapter 33.Competitive Landscape
Chapter 34.Partnerships & M&A
Chapter 35.Key Vendor Analysis
Chapter 36.Marketing Strategy Analysis, Distributors & Traders
Chapter 37.Outlook of the Market
Chapter 38.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Segmentation Analysis
5 axesBy Type
2- 01Stable Isotope Ratio Mass Spectrometer
- 02Laser-based Stable Isotope Analysis
By Application
4- 01Environmental Sciences
- 02Food Analysis
- 03Medical
- 04Industrial
By Isotope Element
5- 01Carbon
- 02Nitrogen
- 03Oxygen
- 04Hydrogen
- 05Sulfur & Others
By End User
5- 01Academic & Research Institutes
- 02Environmental & Regulatory Agencies
- 03Food & Beverage Industry
- 04Pharmaceutical & Biotechnology Companies
- 05Others
By Offering
2- 01Instruments
- 02Software & Services
Segment categories shown for scope reference. See the Summary tab for revenue share by By Type. Full segment-by-segment detail across every axis is available in the sample and full report.
Research approach
A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.
The market is built upward from unit volumes: annual analyzer shipments split between isotope-ratio mass spectrometers and laser-based platforms, each carrying its own realized average selling price by region and end-user type, plus a recurring consumables and service-contract line attached to the installed base. That bottom-up build is checked against the instrumentation-segment revenue Thermo Fisher Scientific and other listed suppliers disclose in their own filings; where a supplier's reported growth diverges from the shipment-and-price build, the correction is made to the underlying volume or price assumption driving that supplier's segment, not by averaging the two figures together.
The four stages
The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.
What the build rests on, and what checks it
The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.
- Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
- Realised pricing by tier and channel, rather than one blended average applied across the whole market
- Take-up and frequency: how much of the addressable base buys, and how often it repeats
- Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
- Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
- Trade and customs flows, where the product crosses borders in a separately recorded form
Data sources
Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.
- Commercial and product leadership at the companies that supply the market
- Procurement and specification leads at the organisations that buy it
- Distributors, integrators and channel partners, where the market is served indirectly
- Regulatory and standards specialists, where approval governs what can be sold at all
- Company filings, annual reports and investor disclosure
- Government statistics, customs records and regulatory registers
- Trade association output and standards-body publications
- Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Interviews target laboratory directors and procurement leads at environmental-testing and food-authentication laboratories, isotope-ratio specialists at university and government research centers, and regulatory-affairs contacts at food-safety and environmental agencies who set testing-method requirements. Distribution and applications-support staff at instrument suppliers are also sampled to understand channel pricing and service-contract structures. Sampling weights North America and Europe, where isotope-ratio testing programs are longest established and procurement cycles are best documented, while including enough Asia Pacific coverage, particularly China and India, to capture the faster-growing laboratory build-out underway there in food-safety and environmental-monitoring procurement.
Desk research draws on national food-safety and customs authorities' import-testing and adulteration-detection program disclosures, environmental-agency water, soil and air-monitoring procurement and compliance records, and the peer-reviewed isotope-geochemistry literature that documents which analytical method a given study used. Trade-body benchmarks from analytical-chemistry and laboratory-accreditation associations inform consumables and service-contract pricing, and publicly listed suppliers' own segment disclosures anchor the revenue check described above. Patent filings around laser-absorption cavity design are used to track which suppliers are extending their platforms into new isotope species.
Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.
Forecasting
The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.
The forecast is built from the pace at which food-fraud and provenance-testing mandates are adopted across major export markets, the rate at which laser-based platforms displace mass spectrometry in cost-sensitive laboratory purchases, and the expansion of tracer-based studies in clinical and pharmaceutical research. Regional forecasts are normalized for the uneven pace of public-agency budget cycles, which move in discrete multi-year steps instead of continuously. The forecast holds if regulatory testing mandates continue expanding rather than plateauing and if laser-based analyzers keep closing the precision gap with mass spectrometry at the pace observed over the historical period.
Triangulation and validation
No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.
Outputs are back-tested against recorded historical shipment and revenue growth for the analyzer categories covered here, checking that the bottom-up build reproduces the historical trajectory before it is extended forward. Segment-share shifts, particularly the move toward laser-based platforms and the growing share held by pharmaceutical and clinical end users, are reviewed against the primary-research interviews described above. Sensitivities are tested on the pace of regulatory-mandate adoption and on average selling price erosion as laser-based platforms mature, since both assumptions have the largest effect on the forecast if they move faster or slower than modeled.
Confidence and limitations
Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.
Confidence is firmest in the largest lines, mass-spectrometry shipments into established research and regulatory laboratories, where historical volumes and pricing are well documented. It is thinner in the pharmaceutical and biotechnology end-use line, where adoption is newer and disclosure is limited, and in isotope-species detail beyond carbon and nitrogen, where reporting is inconsistent across regions. A structural risk that would force a revision is a faster-than-expected shift of environmental-testing budgets toward outsourced contract laboratories, which would move revenue between the end-user categories tracked here without changing the market total.
Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.
Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Stable Isotope Analyzer Market projected to reach?
USD 1835 Million by 2034, CAGR 12.5%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 32% of global revenue through 2034.
05Which segment leads the market?
Stable Isotope Ratio Mass Spectrometer is the largest line by type, at 69.79% of revenue in 2025.
06Who are the key companies profiled?
Picarro, Elementar, Los Gatos Research, Thermo Fisher Scientific, Nu Instruments, Sercon. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.